Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
PharmAthene Reports First Quarter 2017 Financial and Operational Results PR Newswire ANNAPOLIS, Md., May 3, 2017 ANNAPOLIS, Md., May 3, 2017 /PRNewswire/ -- PharmAthene, Inc. (NYSE MKT: PIP), a...
PharmAthene Reports Year-End 2016 Financial and Operational Results PR Newswire ANNAPOLIS, Md., March 14, 2017 ANNAPOLIS, Md., March 14, 2017 /PRNewswire/ -- PharmAthene, Inc. (NYSE MKT: PIP), a...
PharmAthene Announces Record Date and Meeting Date for Special Meeting of Stockholders Regarding Proposed Merger Transaction with Altimmune PR Newswire ANNAPOLIS, Md., March 13, 2017 ANNAPOLIS...
MEMPHIS, Tennessee, February 8, 2017 - InvestorsHub NewsWire -- Platinum Pari-Mutuel Holdings (PPMH), a company focused on innovation and enterprise by acquiring, managing, and operating...
Altimmune to Present at the BIO CEO & Investor Conference PR Newswire GAITHERSBURG, Md., Feb. 6, 2017 GAITHERSBURG, Md., Feb. 6, 2017 /PRNewswire/ -- Altimmune, Inc., a clinical stage...
PharmAthene and Altimmune Announce Merger to Create Immunotherapeutics Company Targeting Infectious Diseases PR Newswire ANNAPOLIS, Md. and GAITHERSBURG, Md., Jan. 19, 2017 ANNAPOLIS, Md. and...
PharmAthene Declares $2.91 Special Cash Dividend on Common Stock Final Payment of $83.9 Million Received from SIGA of $217 Million Total Judgment PR Newswire ANNAPOLIS, Md., Nov. 17, 2016...
PharmAthene Receives Final Payment from SIGA of $83.9 Million - Award amount totals $217 million - PR Newswire ANNAPOLIS, Md., Nov. 16, 2016 ANNAPOLIS, Md., Nov. 16, 2016 /PRNewswire/...
PharmAthene Reports Third Quarter 2016 Financial and Operational Results PR Newswire ANNAPOLIS, Md., Nov. 4, 2016 ANNAPOLIS, Md., Nov. 4, 2016 /PRNewswire/ -- PharmAthene, Inc. (NYSE MKT: PIP), a...
PharmAthene Announces Receipt of Payments from SIGA PR Newswire ANNAPOLIS, Md., Sept. 16, 2016 ANNAPOLIS, Md., Sept. 16, 2016 /PRNewswire/ -- PharmAthene, Inc. (NYSE MKT: PIP), a biodefense...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
